Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 208

1.

Antibiotics for Acute Rhinosinusitis in Adults.

Franck N, Zehtabchi S.

Am Fam Physician. 2019 Oct 1;100(7):Online. No abstract available.

PMID:
31573155
2.

Is social cognitive training efficient in autism? A pilot single-case study using the RC2S+ program.

Peyroux E, Franck N.

Neurocase. 2019 Dec;25(6):217-224. doi: 10.1080/13554794.2019.1666877. Epub 2019 Sep 15.

PMID:
31522609
3.

Functioning and cognitive characteristics of clozapine users referred to psychosocial rehabilitation centers: A REHABase cohort study.

Verdoux H, Quiles C, Cervello S, Dubreucq J, Bon L, Massoubre C, Pommier R, Legros-Lafarge E, Jaafari N, Guillard-Bouhet N, Chéreau-Boudet I, Couhet G, Plasse J, Franck N.

Psychiatry Res. 2019 Nov;281:112543. doi: 10.1016/j.psychres.2019.112543. Epub 2019 Aug 28.

PMID:
31493715
4.

Exploratory case study of monozygotic twins with 22q11.2DS provides further clues to circumscribe neurocognitive markers of psychotic symptoms.

Favre E, Leleu A, Peyroux E, Baudouin JY, Franck N, Demily C.

Neuroimage Clin. 2019 Aug 17;24:101987. doi: 10.1016/j.nicl.2019.101987. [Epub ahead of print]

5.

Encephalitis induced by immune checkpoint inhibitors in metastatic melanoma: a monocentric retrospective study.

Galmiche S, Lheure C, Kramkimel N, Franck N, Boitier F, Dupin N, Turc G, Psimaras D, Aractingi S, Guégan S.

J Eur Acad Dermatol Venereol. 2019 Jun 20. doi: 10.1111/jdv.15756. [Epub ahead of print] No abstract available.

PMID:
31219194
6.

Corpus callosum metrics predict severity of visuospatial and neuromotor dysfunctions in ARID1B mutations with Coffin-Siris syndrome.

Demily C, Duwime C, Lopez C, Hemimou C, Poisson A, Plasse J, Robert MP, Dénier C, Rossi M, Franck N, Besmond C, Barcia G, Boddaert N, Munnich A, Vaivre-Douret L.

Psychiatr Genet. 2019 Dec;29(6):237-242. doi: 10.1097/YPG.0000000000000225.

PMID:
30933046
7.

A reflection upon methods to explore timing in patients with schizophrenia.

Martin B, Franck N, Giersch A.

Psych J. 2019 Mar;8(1):82-89. doi: 10.1002/pchj.268.

PMID:
30912627
8.

[Impact of therapeutic advice on prescription of psychotropics for patients with serious mental illness].

Lebas E, Clerc B, Mangavelle J, Megard R, Franck N.

Encephale. 2019 Sep;45(4):304-311. doi: 10.1016/j.encep.2018.11.006. Epub 2019 Mar 20. French.

PMID:
30902340
9.

Cutaneous lymphomas appearing during treatment with biologics: 44 cases from the French Study Group on Cutaneous Lymphomas and French Pharmacovigilance Database.

Dequidt L, Franck N, Sanchez-Pena P, Dalle S, Adamski H, Boulinguez S, Ingen-Housz-Oro S, Ram-Wolff C, Boccara O, Bonnet N, Cortes B, Gouraud A, Grange F, Le Corre Y, Quereux G, De Masson A, Schmutz JL, Skowron F, Verneuil L, Beylot-Barry M.

Br J Dermatol. 2019 Sep;181(3):616-618. doi: 10.1111/bjd.17834. Epub 2019 May 29. No abstract available.

PMID:
30835817
10.

Neural and cognitive correlates of stigma and social rejection in individuals with Serious Mental Illness (SMI): A systematic review of the literature.

J D, N F.

Psychiatry Res. 2019 Apr;274:146-158. doi: 10.1016/j.psychres.2019.02.023. Epub 2019 Feb 11.

PMID:
30784783
11.

Neuroimaging Studies of Cognitive Function in Schizophrenia.

Penadés R, Franck N, González-Vallespí L, Dekerle M.

Adv Exp Med Biol. 2019;1118:117-134. doi: 10.1007/978-3-030-05542-4_6. Review.

PMID:
30747420
12.

An implicit and reliable neural measure quantifying impaired visual coding of facial expression: evidence from the 22q11.2 deletion syndrome.

Leleu A, Favre E, Yailian A, Fumat H, Klamm J, Amado I, Baudouin JY, Franck N, Demily C.

Transl Psychiatry. 2019 Feb 4;9(1):67. doi: 10.1038/s41398-019-0411-z.

13.

Satisfaction and Needs in Serious Mental Illness and Autism Spectrum Disorder: The REHABase Psychosocial Rehabilitation Project.

Franck N, Bon L, Dekerle M, Plasse J, Massoubre C, Pommier R, Legros-Lafarge E, Jaafari N, Guillard-Bouhet N, Quilès C, Couhet G, Verdoux H, Gouache B, Martin B, Cervello S, Demily C, Dubreucq J.

Psychiatr Serv. 2019 Apr 1;70(4):316-323. doi: 10.1176/appi.ps.201800420. Epub 2019 Jan 29.

PMID:
30691384
14.

From "under" to "over" social cognition in schizophrenia: Is there distinct profiles of impairments according to negative and positive symptoms?

Peyroux E, Prost Z, Danset-Alexandre C, Brenugat-Herne L, Carteau-Martin I, Gaudelus B, Jantac C, Attali D, Amado I, Graux J, Houy-Durand E, Plasse J, Franck N.

Schizophr Res Cogn. 2018 Nov 8;15:21-29. doi: 10.1016/j.scog.2018.10.001. eCollection 2019 Mar.

15.

Large International Validation of ABSIS and PDAI Pemphigus Severity Scores.

Hébert V, Boulard C, Houivet E, Duvert Lehembre S, Borradori L, Della Torre R, Feliciani C, Fania L, Zambruno G, Camaioni DB, Didona B, Marinovic B, Schmidt E, Schumacher N, Hünefeld C, Schanz S, Kern JS, Hofmann S, Bouyeure AC, Picard-Dahan C, Prost-Squarcioni C, Caux F, Alexandre M, Ingen-Housz-Oro S, Bagot M, Tancrede-Bohin E, Bouaziz JD, Franck N, Vabres P, Labeille B, Richard MA, Delaporte E, Dupuy A, D'Incan M, Quereux G, Skowro F, Paul C, Livideanu CB, Beylot-Barry M, Doutre MS, Avenel-Audran M, Bedane C, Bernard P, Machet L, Maillard H, Jullien D, Debarbieux S, Sassolas B, Misery L, Abasq C, Dereure O, Lagoutte P, Ferranti V, Werth VP, Murrell DF, Hertl M, Benichou J, Joly P; French Study Group on Autoimmune Bullous Skin Diseases; Autoimmune Bullous Skin Disease Task Force of the European Academy of Dermatology and Venereology.

J Invest Dermatol. 2019 Jan;139(1):31-37. doi: 10.1016/j.jid.2018.04.042. Epub 2018 Oct 6. Review.

PMID:
30301637
16.

Unresectable Non-metastatic Primary Melanoma: Complete Remission Following Treatment with Anti-Programmed-cell-death-receptor 1.

Lheure C, Hoffmann C, Kramkimel N, Plée J, Franck N, Vanhaecke C, Goldman-Lévy G, Bataillon G, Damotte D, Dupin N, Aractingi S, Grange F, Guégan S.

Acta Derm Venereol. 2019 Jan 1;99(1):107-108. doi: 10.2340/00015555-3028. No abstract available.

17.

Overview of Social Cognitive Dysfunctions in Rare Developmental Syndromes With Psychiatric Phenotype.

Morel A, Peyroux E, Leleu A, Favre E, Franck N, Demily C.

Front Pediatr. 2018 May 3;6:102. doi: 10.3389/fped.2018.00102. eCollection 2018. Review.

18.

Evaluation of Morpho-Physiological Traits Adjustment of Prosopis tamarugo Under Long-Term Groundwater Depletion in the Hyper-Arid Atacama Desert.

Garrido M, Silva H, Franck N, Arenas J, Acevedo E.

Front Plant Sci. 2018 Apr 9;9:453. doi: 10.3389/fpls.2018.00453. eCollection 2018.

19.

Minimal Self and Timing Disorders in Schizophrenia: A Case Report.

Martin B, Franck N, Cermolacce M, Coull JT, Giersch A.

Front Hum Neurosci. 2018 Apr 6;12:132. doi: 10.3389/fnhum.2018.00132. eCollection 2018.

20.

A decision tree for the genetic diagnosis of deficiency of adenosine deaminase 2 (DADA2): a French reference centres experience.

Rama M, Duflos C, Melki I, Bessis D, Bonhomme A, Martin H, Doummar D, Valence S, Rodriguez D, Carme E, Genevieve D, Heimdal K, Insalaco A, Franck N, Queyrel-Moranne V, Tieulie N, London J, Uettwiller F, Georgin-Lavialle S, Belot A, Koné-Paut I, Hentgen V, Boursier G, Touitou I, Sarrabay G.

Eur J Hum Genet. 2018 Jul;26(7):960-971. doi: 10.1038/s41431-018-0130-6. Epub 2018 Apr 23.

21.

Subthreshold social cognitive deficits may be a key to distinguish 22q11.2DS from schizophrenia.

Peyroux E, Rigard C, Saucourt G, Poisson A, Plasse J, Franck N, Demily C.

Early Interv Psychiatry. 2019 Apr;13(2):304-307. doi: 10.1111/eip.12557. Epub 2018 Mar 25.

PMID:
29575660
22.

The impact of cognitive remediation on cerebral activity in schizophrenia: Systematic review of the literature.

Bon L, Franck N.

Brain Behav. 2018 Feb 7;8(3):e00908. doi: 10.1002/brb3.908. eCollection 2018 Mar.

23.

Responding to the needs of the population suffering from severe mental disorders by a multifaceted territorial approach: Reorganization of the French mental health system.

Franck N, Laforcade M.

Perspect Psychiatr Care. 2018 Oct;54(4):527-529. doi: 10.1111/ppc.12264. Epub 2018 Feb 25.

PMID:
29479719
24.

T-cell papulosis associated with B-cell malignancy: a distinctive clinicopathologic entity.

Visseaux L, Durlach A, Barete S, Beylot-Barry M, Bonnet N, Chassine A, Franck N, Herve G, Leclec'h C, Machet L, Ingen-Housz-Oro S, Petrella T, Vergier B, Ortonne N, Grange F.

J Eur Acad Dermatol Venereol. 2018 Sep;32(9):1469-1475. doi: 10.1111/jdv.14805. Epub 2018 Feb 12.

PMID:
29356170
25.

Anaplastic Kaposi's sarcoma: 5 cases of a rare and aggressive type of Kaposi's sarcoma.

Chapalain M, Goldman-Lévy G, Kramkimel N, Carlotti A, Franck N, Lheure C, Audard V, Avril MF, Marcelin AG, Damotte D, Terris B, Aractingi S, Dupin N.

Ann Dermatol Venereol. 2018 Jan;145(1):21-28. doi: 10.1016/j.annder.2017.09.593. Epub 2017 Dec 28.

PMID:
29290414
26.

Somatic mosaicism for SLC1A1 mutation supports threshold effect and familial aggregation in schizophrenia spectrum disorders.

Demily C, Hubert L, Franck N, Poisson A, Munnich A, Besmond C.

Schizophr Res. 2018 Jul;197:583-584. doi: 10.1016/j.schres.2017.11.028. Epub 2017 Nov 28. No abstract available.

PMID:
29195747
27.

Weight loss induced by quetiapine in a 22q11.2DS patient.

Demily C, Poisson A, Thibaut F, Franck N.

Mol Genet Metab Rep. 2017 Oct 17;13:95-96. doi: 10.1016/j.ymgmr.2017.10.002. eCollection 2017 Dec. No abstract available.

28.

Fragile temporal prediction in patients with schizophrenia is related to minimal self disorders.

Martin B, Franck N, Cermolacce M, Falco A, Benair A, Etienne E, Weibel S, Coull JT, Giersch A.

Sci Rep. 2017 Aug 15;7(1):8278. doi: 10.1038/s41598-017-07987-y.

29.

Rehabilitation Interventions to Promote Recovery from Schizophrenia: A Systematic Review.

Morin L, Franck N.

Front Psychiatry. 2017 Jun 12;8:100. doi: 10.3389/fpsyt.2017.00100. eCollection 2017. Review.

30.

[Preventing violence in schizophrenia with cognitive remediation].

Darmedru C, Demily C, Franck N.

Encephale. 2018 Apr;44(2):158-167. doi: 10.1016/j.encep.2017.05.001. Epub 2017 Jun 20. Review. French.

PMID:
28641817
31.

Erratum to: Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients.

Heidelberger V, Goldwasser F, Kramkimel N, Jouinot A, Huillard O, Boudou-Rouquette P, Chanal J, Arrondeau J, Franck N, Alexandre J, Blanchet B, Leroy K, Avril MF, Dupin N, Aractingi S.

Invest New Drugs. 2017 Aug;35(4):537. doi: 10.1007/s10637-017-0475-7. No abstract available.

PMID:
28597150
32.

Clinical parameters associated with anti-programmed death-1 (PD-1) inhibitors-induced tumor response in melanoma patients.

Heidelberger V, Goldwasser F, Kramkimel N, Jouinot A, Franck N, Arrondeau J, Guégan S, Mansuet-Lupo A, Alexandre J, Damotte D, Avril MF, Dupin N, Aractingi S.

Invest New Drugs. 2017 Dec;35(6):842-847. doi: 10.1007/s10637-017-0476-6. Epub 2017 May 31.

PMID:
28569347
33.

Altered miR-29 Expression in Type 2 Diabetes Influences Glucose and Lipid Metabolism in Skeletal Muscle.

Massart J, Sjögren RJO, Lundell LS, Mudry JM, Franck N, O'Gorman DJ, Egan B, Zierath JR, Krook A.

Diabetes. 2017 Jul;66(7):1807-1818. doi: 10.2337/db17-0141. Epub 2017 Apr 12.

34.

Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients.

Heidelberger V, Goldwasser F, Kramkimel N, Jouinot A, Huillard O, Boudou-Rouquette P, Chanal J, Arrondeau J, Franck N, Alexandre J, Blanchet B, Leroy K, Avril MF, Dupin N, Aractingi S.

Invest New Drugs. 2017 Aug;35(4):436-441. doi: 10.1007/s10637-017-0464-x. Epub 2017 Apr 10. Erratum in: Invest New Drugs. 2017 Jun 9;:.

PMID:
28396974
35.

[Dermatoses and herpes superinfection: A retrospective study of 34 cases].

Seta V, Fichel F, Méritet JF, Bouam S, Franck N, Avril MF, Dupin N.

Ann Dermatol Venereol. 2017 Mar;144(3):176-181. doi: 10.1016/j.annder.2017.01.011. Epub 2017 Feb 24. French.

PMID:
28242091
36.

Cognitive remediation and social cognitive training for violence in schizophrenia: a systematic review.

Darmedru C, Demily C, Franck N.

Psychiatry Res. 2017 May;251:266-274. doi: 10.1016/j.psychres.2016.12.062. Epub 2017 Feb 9. Review.

PMID:
28219026
37.

Neutrophilic eccrine hidradenitis in two patients treated with BRAF inhibitors: a new cutaneous adverse event.

Herms F, Franck N, Kramkimel N, Fichel F, Delaval L, Laurent-Roussel S, Carlotti A, Avril MF.

Br J Dermatol. 2017 Jun;176(6):1645-1648. doi: 10.1111/bjd.15259. Epub 2017 Apr 16.

PMID:
28005274
38.

Subcutaneous Panniculitis-like T-cell Lymphoma: Immunosuppressive Drugs Induce Better Response than Polychemotherapy.

Michonneau D, Petrella T, Ortonne N, Ingen-Housz-Oro S, Franck N, Barete S, Battistella M, Beylot-Barry M, Vergier B, Maynadié M, Bodemer C, Hermine O, Bagot M, Brousse N, Fraitag S.

Acta Derm Venereol. 2017 Mar 10;97(3):358-364. doi: 10.2340/00015555-2543.

39.

Cognitive behavioral therapy in 22q11.2 microdeletion with psychotic symptoms: What do we learn from schizophrenia?

Demily C, Franck N.

Eur J Med Genet. 2016 Nov;59(11):596-603. doi: 10.1016/j.ejmg.2016.09.007. Epub 2016 Sep 14.

PMID:
27639442
40.

Clinical and Biological Characteristics of 40 Patients With Neurosyphilis and Evaluation of Treponema pallidum Nested Polymerase Chain Reaction in Cerebrospinal Fluid Samples.

Vanhaecke C, Grange P, Benhaddou N, Blanche P, Salmon D, Parize P, Lortholary O, Caumes E, Pelloux I, Epaulard O, Guinard J, Dupin N; Neurosyphilis Network; Neurosyphilis network.

Clin Infect Dis. 2016 Nov 1;63(9):1180-1186. Epub 2016 Sep 1.

PMID:
27585981
41.

Validation of the Warwick-Edinburgh Mental Well-Being Scale (WEMWBS) in French psychiatric and general populations.

Trousselard M, Steiler D, Dutheil F, Claverie D, Canini F, Fenouillet F, Naughton G, Stewart-Brown S, Franck N.

Psychiatry Res. 2016 Nov 30;245:282-290. doi: 10.1016/j.psychres.2016.08.050. Epub 2016 Aug 20.

PMID:
27565700
42.

[How to involve patients with schizophrenia in their treatment using psychoeducation].

Franck N.

Presse Med. 2016 Sep;45(9):742-8. doi: 10.1016/j.lpm.2016.07.012. Epub 2016 Aug 12. French.

PMID:
27526987
43.

Periostitis in secondary syphilis with prozone phenomenon.

Mahévas T, Chanal J, Franck N, Laurent S, Avril MF, Dupin N.

Rheumatology (Oxford). 2016 Nov;55(11):1931. Epub 2016 Aug 7. No abstract available.

PMID:
27498354
44.

Improving Facial Emotion Recognition in Schizophrenia: a Controlled Study Comparing Specific and Attentional Focused Cognitive Remediation.

Gaudelus B, Virgile J, Geliot S; GAÏA/RECOS Study Team, Franck N.

Front Psychiatry. 2016 Jun 21;7:105. doi: 10.3389/fpsyt.2016.00105. eCollection 2016.

45.

Dissociating Affective and Cognitive Theory of Mind in Recently Detoxified Alcohol-Dependent Individuals.

Maurage P, D'Hondt F, de Timary P, Mary C, Franck N, Peyroux E.

Alcohol Clin Exp Res. 2016 Sep;40(9):1926-34. doi: 10.1111/acer.13155. Epub 2016 Jul 18.

PMID:
27427391
46.

Improving Social Cognition in People with Schizophrenia with RC2S: Two Single-Case Studies.

Peyroux E, Franck N.

Front Psychiatry. 2016 Apr 25;7:66. doi: 10.3389/fpsyt.2016.00066. eCollection 2016.

47.

Pembrolizumab-induced necrotic myositis in a patient with metastatic melanoma.

Vallet H, Gaillet A, Weiss N, Vanhaecke C, Saheb S, Touitou V, Franck N, Kramkimel N, Borden A, Touat M, Ricard D, Verny M, Maisonobe T, Psimaras D.

Ann Oncol. 2016 Jul;27(7):1352-3. doi: 10.1093/annonc/mdw126. Epub 2016 Mar 2. No abstract available.

PMID:
26940685
48.

Theory of mind in adolescents with early-onset schizophrenia: correlations with clinical assessment and executive functions.

Bourgou S, Halayem S, Amado I, Triki R, Bourdel MC, Franck N, Krebs MO, Tabbane K, Bouden A.

Acta Neuropsychiatr. 2016 Aug;28(4):232-8. doi: 10.1017/neu.2016.3. Epub 2016 Feb 26.

PMID:
26916502
49.

«Cognitus & Moi»: A Computer-Based Cognitive Remediation Program for Children with Intellectual Disability.

Demily C, Rigard C, Peyroux E, Chesnoy-Servanin G, Morel A, Franck N.

Front Psychiatry. 2016 Feb 3;7:10. doi: 10.3389/fpsyt.2016.00010. eCollection 2016.

50.

Calculation of cut-off values based on the Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and Pemphigus Disease Area Index (PDAI) pemphigus scoring systems for defining moderate, significant and extensive types of pemphigus.

Boulard C, Duvert Lehembre S, Picard-Dahan C, Kern JS, Zambruno G, Feliciani C, Marinovic B, Vabres P, Borradori L, Prost-Squarcioni C, Labeille B, Richard MA, Ingen-Housz-Oro S, Houivet E, Werth VP, Murrell DF, Hertl M, Benichou J, Joly P; International Pemphigus Study Group.

Br J Dermatol. 2016 Jul;175(1):142-9. doi: 10.1111/bjd.14405. Epub 2016 Apr 3.

PMID:
26800395

Supplemental Content

Loading ...
Support Center